ARTICLE | Clinical News
Lifecore regulatory update
July 15, 1996 7:00 AM UTC
LCBM received an additional 510(k) clearance from the FDA for its Hapset Hydroxylapatite Bone Graft Plaster. The clearance allows LCBM to market the product for use outside of the oral cavity in maxil...